US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 1.500
  • +0.080+5.63%
Close Dec 27 16:00 ET
  • 1.440
  • -0.060-4.00%
Post 20:01 ET
185.30MMarket Cap-2.50P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mersana Therapeutics Q3 2024 Earnings Date

Currency：USDNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
7.56M
12.60M
+5.04M
Beat Est.
-1.77%
+63.65%
+66.60%
EPS
-0.17
-0.09
+0.08
Beat Est.
+50.50%
+74.29%
+48.04%
Analyst Rating
Strong Buy

Dec 4, 2024

Mersana Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.898M--
--2024/Q4-- / 7.641M--
Nov 13, 20242024/Q312.598M / 7.562M--
Aug 13, 20242024/Q22.293M / 8.721M--
May 9, 20242024/Q19.245M / 8.289M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.898M--
--2024/Q4-- / 7.641M--
Nov 13, 20242024/Q312.598M / 7.562M--
Aug 13, 20242024/Q22.293M / 8.721M--
May 9, 20242024/Q19.245M / 8.289M--

Unlock Free Earnings Estimates

Mersana Therapeutics Earnings Reports

  • Mersana Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 13 08:52 ET

  • Mersana Therapeutics | 8-K: Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

    Nov 13 07:33 ET

  • Mersana Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 09:02 ET

  • Mersana Therapeutics | 8-K: Mersana Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

    Aug 13 07:22 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 4, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data